Union Bancaire Privee UBP SA Acquires 8,230 Shares of Intuitive Surgical, Inc. $ISRG

Union Bancaire Privee UBP SA boosted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 46.7% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 25,860 shares of the medical equipment provider’s stock after buying an additional 8,230 shares during the period. Union Bancaire Privee UBP SA’s holdings in Intuitive Surgical were worth $14,973,000 as of its most recent SEC filing.

A number of other institutional investors have also recently bought and sold shares of the stock. Kilter Group LLC bought a new stake in shares of Intuitive Surgical during the second quarter worth $27,000. Greykasell Wealth Strategies Inc. bought a new stake in Intuitive Surgical in the 3rd quarter valued at $27,000. Caitlin John LLC bought a new stake in Intuitive Surgical in the 3rd quarter valued at $30,000. KERR FINANCIAL PLANNING Corp acquired a new position in Intuitive Surgical in the 3rd quarter worth $33,000. Finally, Guerra Advisors Inc bought a new position in Intuitive Surgical during the 3rd quarter worth about $37,000. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Stock Up 0.5%

Shares of Intuitive Surgical stock opened at $479.93 on Friday. Intuitive Surgical, Inc. has a 12-month low of $425.00 and a 12-month high of $603.88. The stock has a market cap of $170.44 billion, a P/E ratio of 60.83, a P/E/G ratio of 3.68 and a beta of 1.66. The business’s 50 day moving average is $505.00 and its 200-day moving average is $512.62.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share for the quarter, beating the consensus estimate of $2.27 by $0.26. The business had revenue of $2.87 billion during the quarter, compared to analysts’ expectations of $2.72 billion. Intuitive Surgical had a net margin of 28.38% and a return on equity of 15.06%. The firm’s revenue was up 18.8% on a year-over-year basis. During the same period last year, the business earned $2.21 earnings per share. On average, sell-side analysts expect that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Insider Buying and Selling

In other news, SVP Patricia L. Wadors sold 220 shares of the company’s stock in a transaction dated Friday, February 27th. The shares were sold at an average price of $499.71, for a total value of $109,936.20. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, EVP Myriam Curet sold 421 shares of Intuitive Surgical stock in a transaction dated Wednesday, February 11th. The stock was sold at an average price of $494.96, for a total value of $208,378.16. Following the transaction, the executive vice president owned 409 shares of the company’s stock, valued at $202,438.64. The trade was a 50.72% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders have sold 32,943 shares of company stock worth $17,279,568. Corporate insiders own 0.70% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages have recently commented on ISRG. Wall Street Zen lowered Intuitive Surgical from a “buy” rating to a “hold” rating in a report on Saturday, February 7th. The Goldman Sachs Group reiterated a “buy” rating and set a $714.00 price objective on shares of Intuitive Surgical in a report on Friday, January 9th. Robert W. Baird dropped their target price on Intuitive Surgical from $655.00 to $645.00 and set an “outperform” rating on the stock in a research report on Friday, January 23rd. Royal Bank Of Canada boosted their target price on Intuitive Surgical from $625.00 to $650.00 and gave the company an “outperform” rating in a research note on Wednesday, December 17th. Finally, TD Cowen raised Intuitive Surgical to a “strong-buy” rating in a research report on Tuesday, January 27th. Two equities research analysts have rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating, six have given a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $614.95.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.